CEACAM Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of CEACAM Antibodies for research focused on carcinoembryonic antigen-related cell adhesion molecules (CEACAMs). CEACAM monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CEACAMs are essential mediators in cell adhesion processes and significantly influence immune response, tumor progression, and metastasis. The involvement of CEACAMs in various physiological and pathological conditions has established them as key targets in cancer biology and immunology research. CEACAM expression patterns serve as valuable indicators for disease progression and potential therapeutic interventions. Investigating CEACAM functions continues to reveal new possibilities in cancer treatment and diagnostic strategies. Understanding CEACAM mechanisms helps researchers develop more effective therapeutic approaches. The extensive selection of CEACAM monoclonal antibodies from Santa Cruz Biotechnology enables researchers worldwide to advance scientific understanding of cancer biology and immunology.